<!doctype html><html lang="zh-hans"><head><meta charset="utf-8"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>Baricitinib治疗可降低Covid-19患者的死亡率Baricitinib treatment linked to reduced mortality in Covid-19 patients</title><link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/css/bootstrap.min.css" integrity="sha384-ggOyR0iXCbMQv3Xipma34MD+dH/1fQ784/j6cY/iJTQUOhcWr7x9JvoRxT2MZw1T" crossorigin="anonymous"><link rel="stylesheet" href="/img/css.css?random="><link data-rh="true" rel="icon" href="/img/favicon.ico"/><script>var _hmt = _hmt || [];(function() {var hm = document.createElement("script");hm.src = "https://hm.baidu.com/hm.js?03c1a0f31299b4a2fbb83c34d6beaac9";var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s);})();</script><script data-ad-client="ca-pub-6067137220025946" async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script><script type="text/javascript" src="https://platform-api.sharethis.com/js/sharethis.js#property=5effb96910009800120b8d4d&product=inline-share-buttons" async="async"></script></head><body><div id="my_header"><div class="container"><nav class="navbar navbar-expand-lg"><a class="navbar-brand" href="/"><img alt="diglog" src="/img/logo.v1.gif" class="rounded-sm"></a><button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarNavAltMarkup" aria-controls="navbarNavAltMarkup" aria-expanded="false" aria-label="Toggle navigation"><span class="navbar-toggler-icon"></span></button><div class="collapse navbar-collapse" id="navbarNavAltMarkup"><div class="navbar-nav"></div></div></nav></div></div><div class="container"><div id="my_content"><h1 class="page_narrow">Baricitinib treatment linked to reduced mortality in Covid-19 patients<br/>Baricitinib治疗可降低Covid-19患者的死亡率</h1><div class="row"><div class="col-lg-12 col-12"><div class="my_story_list_item shadow p-3 mb-5 bg-white rounded"><div class="story_page_pub_time page_narrow">2020-11-30 04:46:13</div><div class="story_img_container"><a href="http://img2.diglog.com/img/2020/11/d576e3e12fe65d6b8281e6a4daf1fb1f.jpg"><img src="http://img2.diglog.com/img/2020/11/d576e3e12fe65d6b8281e6a4daf1fb1f.jpg" class="img-fluid my_story_img" onerror="this.style.display='none'"></a></div><div class="page_narrow text-break page_content"><p>The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according to translational research by an international team coordinated by researchers from Karolinska Institutet in Sweden. The findings, published in the journal Science Advances, support the continuation of ongoing randomized clinical trials.</p><p>根据瑞典Karolinska研究所的研究人员协调的国际研究小组的研究，类风湿关节炎药物Baricitinib可以阻断病毒进入并降低COVID-19中重度患者的死亡率。这项发现发表在《科学进展》杂志上，支持正在进行的随机临床试验的继续进行。</p><p>  “We are pleased to report a 71 percent reduction in mortality for the group receiving baricitinib in addition to standard care,” says  Volker Lauschke, corresponding author and associate professor of personalized medicine and drug development at the  Department of Physiology and Pharmacology, Karolinska Institutet. “These results are especially encouraging seeing as the study included a large cohort of elderly patients, a group that is often excluded in other trials.”</p><p>  Karolinska研究所生理学和药理学系的通讯作者，个性化医学和药物开发副教授Volker Lauschke说：“我们很高兴地报告，除标准治疗外，接受Baricitinib治疗的患者的死亡率降低了71％。” “看到这项研究包括大量的老年患者，这些结果尤其令人鼓舞，这一群体在其他试验中经常被排除在外。”</p><p> In the study, 83 patients hospitalized with COVID-19 pneumonia in Italy and Spain were treated with baricitinib in addition to standard care. Of these, 17 percent suffered an adverse outcome that resulted in death or invasive mechanical ventilation. This compared to 35 percent in the matched control group of 83 patients who received standard care only. The patients had a median age of 81 years.</p><p> 在这项研究中，意大利和西班牙的83例因COVID-19肺炎住院的患者除接受标准治疗外还接受了Baricitinib治疗。其中17％的不良后果导致死亡或有创机械通气。相比之下，只有83名患者接受标准护理的对照组为35％。患者的中位年龄为81岁。</p><p>  The drug was generally well tolerated with a reduction in inflammation from the first treatment days, according to the researchers. Previously reported side-effects of long-term baricitinib use, including coagulopathy and thrombosis, were not evident in any of the patients, possibly due to treatment with anti-coagulating medicine. However, some adverse events including bacterial infections and gastrointestinal and cardiovascular complications were noted, although these were also observed in the control group so it is unclear what, if anything, can be ascribed to baricitinib.</p><p>  研究人员称，从开始治疗的第一天起，该药物通常就具有良好的耐受性，并且炎症减轻。先前报道的长期使用巴西替尼的副作用（包括凝血病和血栓形成）在任何患者中均不明显，可能是由于使用抗凝药物治疗所致。然而，尽管在对照组中也观察到了一些不良事件，包括细菌感染以及胃肠道和心血管并发症，但尚不清楚是什么可以归因于baricitinib。</p><p> In a  prior study, the same team of researchers reported how they used artificial intelligence (AI) to identify baricitinib as a promising repurposing candidate for COVID-19. That study also showed how the drug inhibited inflammation and reduced the viral load of SARS-CoV-2.</p><p> 在先前的研究中，同一组研究人员报告了他们如何使用人工智能（AI）来确定巴利替尼是COVID-19的有希望的替代用途。该研究还显示了该药物如何抑制炎症并降低SARS-CoV-2的病毒载量。</p><p>  In the current study, the researchers elaborated on those findings by demonstrating that interferons, cytokines made and released by host cells in response to viruses, significantly increases the expression of the ACE2 receptor, which acts as an entry point for SARS-CoV-2 into human cells. While liver injury is commonly observed in severe COVID-19, mechanisms and dynamics of SARS-CoV-2 infections had not been investigated in this organ.</p><p>  在当前的研究中，研究人员通过证明干扰素，宿主细胞响应病毒而产生和释放的细胞因子，显着增加了ACE2受体的表达，而ACE2受体是SARS-CoV-2进入人体的切入点，从而详细阐述了这些发现。人类细胞。虽然在严重的COVID-19中通常观察到肝损伤，但尚未在该器官中研究SARS-CoV-2感染的机制和动力学。</p><p> By combining 3D mini organs of human liver cells, RNA sequencing and super-resolution microscopy, the scientists were able to show that barcitinib reversed ACE2 gene expression changes triggered by interferons and reduced SARS-CoV-2 infectivity. Interestingly, interferons did not have the same effect on the ACE2 receptor in lung organoids, suggesting that these signaling proteins affect pulmonary and liver organs differently.</p><p> 通过将人类肝细胞的3D微型器官，RNA测序和超分辨率显微镜相结合，科学家们能够证明巴西替尼逆转了由干扰素触发的ACE2基因表达变化，并降低了SARS-CoV-2的感染性。有趣的是，干扰素对肺类器官中的ACE2受体没有相同的作用，表明这些信号蛋白对肺和肝器官的影响不同。</p><p>  “Our findings explain the dual anti-cytokine and anti-viral actions of baricitinib and support further evaluation in randomized control trials,” says  Ali Mirazimi, adjunct professor at the  Department of Laboratory Medicine, Karolinska Institutet, and co-author of the study.</p><p>该研究的共同作者，卡罗林斯卡研究所实验室医学系副教授阿里·米拉齐米（Ali Mirazimi）说：“我们的发现解释了巴利替尼的双重抗细胞因子和抗病毒作用，并支持在随机对照试验中进行进一步评估。”</p><p> The researchers note that a limitation of the study was the lack of a placebo control group, which is included in industry-sponsored randomized controlled trials that are currently ongoing.</p><p> 研究人员指出，这项研究的局限性在于缺乏安慰剂对照组，而安慰剂对照组目前仍在行业赞助的随机对照试验中。</p><p> The clinical study was led by researchers at Imperial College London, U.K., Complejo Hospitalario Universitario de Albacete, Spain, and the University of Pisa, Italy, while the mechanistic investigations on 3D human tissue models were conducted at Karolinska Institutet.</p><p> 该临床研究由英国伦敦帝国学院，西班牙阿尔巴塞特大学Complejo Hospitalario Universitario de University和意大利比萨大学的研究人员领导，而3D人体组织模型的机械研究是在Karolinska Institutet进行的。</p><p> The research was funded by the Swedish Research Council, the Strategic Research Programmes in Diabetes and Stem Cells and Regenerative Medicine, EU/EFPIA/OICR/McGill/KTH/Diamond Innovative Medicines Initiative, Ricerca Corrente Linea 1 and 3, the National Science Foundation, the National Institutes of Health, the Department of Energy, CIBERFES, Instituto de Salud Carlos III, Ministerio de Economía y Competitividad, España. Ayuda cofinanciada por el Fondo Europeo de Desarrollo Regional FEDER Una Manera de hacer Europa, Imperial BRC, ECMC, the NIHR and AAC.</p><p> 该研究由瑞典研究委员会，糖尿病和干细胞与再生医学战略研究计划，EU / EFPIA / OICR / McGill / KTH /钻石创新医学计划，Ricerca Corrente Linea 1和3，国家科学基金会资助。美国国家卫生研究院，能源部，CIBERFES，萨洛德·卡洛斯三世研究所，西班牙经济与竞争大臣。 Ayuda cofinanciada por el Fondo Europeo de Desarrollo区域FEDER Una Manera de hacer Europa，帝国BRC，ECMC，NIHR和AAC。</p><p> The authors of the paper have reported several conflicts of interest, including lecture fees and research grants from pharmaceutical companies that own baricitinib. Some of the authors have founded companies that feature technologies mentioned in this study. For a complete list of disclosures, please see the full article.</p><p> 该论文的作者报告了一些利益冲突，包括讲课费和拥有Baricitinib的制药公司的研究资助。一些作者创建了具有这项研究中提到的技术的公司。有关披露的完整列表，请参阅全文。</p><p>  Baricitinib is a once-daily oral drug used for treatment of adult patients with moderate to severe rheumatoid arthritis.</p><p>  Baricitinib是每日一次的口服药物，用于治疗中度至重度类风湿关节炎的成年患者。</p><p>  It acts as an inhibitor of janus kinase, a type of enzyme that acts as an “on” or “off” switch in many cellular functions.</p><p>  它充当janus激酶的抑制剂，janus激酶是一种在许多细胞功能中充当“开”或“关”开关的酶。</p><p>  The drug has dual functions and acts by interfering with the inflammatory processes of the immune system as well as by directly inhibiting viral entry. It is seen as a potential treatment candidate for COVID-19.</p><p>该药物具有双重功能，可通过干扰免疫系统的炎症过程以及直接抑制病毒进入而发挥作用。它被视为COVID-19的潜在治疗候选药物。</p><p>  “ JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality,” Justin Stebbing, Ginés Sánchez Nievas, Marco Falcone, Sonia Youhanna, Peter Richardson, Silvia Ottaviani, Joanne X. Shen, Christian Sommerauer, Giusy Tiseo, Lorenzo Ghiadoni, Agostino Virdis, Fabio Monzani, Luis Romero Rizos, Francesco Forfori, Almudena Avendaño Céspedes, Salvatore De Marco, Laura Carrozzi, Fabio Lena, Pedro Manuel Sánchez-Jurado, Leonardo Gianluca Lacerenza, Nencioni Cesira, David Caldevilla Bernardo, Antonio Perrella, Laura Niccoli, Lourdes Sáez Méndez, Daniela Matarrese, Delia Goletti, Yee-Joo Tan, Vanessa Monteil, George Dranitsaris, Fabrizio Cantini, Alessio Farcomeni, Shuchismita Dutta, Stephen K. Burley, Haibo Zhang, Mauro Pistello, William Li, Marta Mas Romero, Fernando Andrés Pretel, Rafaela Sánchez Simón-Talero, Rafael García-Molina, Claudia Kutter, James H. Felce, Zehra F. Nizami, Andras G. Miklosi, Josef M. Penninger,Francesco Menichetti, Ali Mirazimi, Pedro Abizanda and Volker M. Lauschke, Science Advances, online November 13, 2020, doi: 10.1126/sciadv.abe4724</p><p>  “ JAK抑制作用可降低SARS-CoV-2肝脏的感染性并调节炎症反应，从而降低发病率和死亡率，”贾斯汀·斯特布汀，吉妮丝·桑切斯·涅瓦斯，马可·法尔科内，索尼亚·尤汉娜，彼得·理查森，西尔维娅·奥塔维亚尼，乔安妮·沉，克里斯蒂安·索默劳尔，朱西Tiseo，Lorenzo Ghiadoni，Agostino Virdis，Fabio Monzani，Luis Romero Rizos，Francesco Forfori，AlmudenaAvendañoCéspedes，Salvatore De Marco，Laura Carrozzi，Fabio Lena，佩德罗·曼努埃尔·桑切斯-朱拉多，莱昂纳多·吉安卢卡·拉尼埃拉·卡迪亚尼佩雷拉（Perrella），劳拉·尼科利（Laura Niccoli），卢尔德·萨雷斯·门德斯（LourdesSáezMéndez），丹妮拉·马塔雷塞（Daniela Matarrese），迪莉娅·哥莱蒂（Diaa Goletti），Yee-Joo Tan，凡妮莎·蒙蒂尔（George Dranitsaris），法布里佐·坎蒂尼（Fabrizio Cantini），阿莱西奥·法尔科曼尼（Alessio Farcomeni），舒奇米蒂塔·杜塔（Shuchismita Dutta），斯蒂芬·K·伯利（Stephen K. Mas Romero，FernandoAndrésPretel，RafaelaSánchezSimón-Talero，RafaelGarcía-Molina，Claudia Kutter，James H.Felce，Zehra F.Nizami，Andras G.Miklosi，Josef M.Penninger，Francesco Menic海蒂（Hetti），阿里·米拉齐米（Ali Mirazimi），佩德罗·阿比坎达（Pedro Abizanda）和沃尔克·劳斯凯克（Volker M.</p></div><div id="story_share_this"><div class="sharethis-inline-share-buttons"></div></div><div class="text-break sotry_link page_narrow"><a target="_blank" href="https://news.ki.se/baricitinib-treatment-linked-to-reduced-mortality-in-covid-19-patients">https://news.ki.se/baricitinib-treatment-linked-to-reduced-mortality-in-covid-19-patients</a></div><div class="story_tags page_narrow"><button type="button" class="btn btn-light my_tag"><a href="/tag/治疗/">#治疗</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/treatment/">#treatment</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/研究/">#研究</a></button></div></div><div class="my_movie_list_item shadow p-3 mb-5 bg-white rounded"><button type="button" class="btn btn-link my_tag"><a href="/tag/web2.0/">#web2.0</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/google/">#google</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/设计/">#设计</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/创意/">#创意</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/摄影/">#摄影</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/图片/">#图片</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/游戏/">#游戏</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/软件/">#软件</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/手机/">#手机</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/视频/">#视频</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/广告/">#广告</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/iphone/">#iphone</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/网站/">#网站</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/免费/">#免费</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/下载/">#下载</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/windows/">#windows</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/苹果/">#苹果</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/微软/">#微软</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/apple/">#apple</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/blog/">#blog</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/firefox/">#firefox</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/音乐/">#音乐</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/博客/">#博客</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/wordpress/">#wordpress</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/恶搞/">#恶搞</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/艺术/">#艺术</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/qq/">#qq</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/web/">#web</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/工具/">#工具</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/分享/">#分享</a></button></div></div></div><div id="my_footer"><div class=""><a href="/tags/">tags</a> <a href="/users/">users</a></div>&copy; 2020 diglog.com </div></div></body></html>